Skip to main content

Advertisement

Table 4 Comparison of clinical and economic outcomes in subcohort of chronic ischemic heart disease

From: Cost-consequence analysis of salvianolate injection for the treatment of coronary heart disease

Outcome Conventional treatment + salvianolate injection (n = 129) Conventional treatment (n = 129) Difference P
Hospital stay (d) 11.9 (± 7.7) 15.5 (± 13.0) − 3.6 < 0.05
Total nitrates dosage (mg) 452.7 (± 490.1) 703.4 (± 845.2) − 250.7 < 0.05
Total medical costs (CNY) 12,694.9 (± 20,609.5) 17,034.4 (± 21,251.3) − 4339.5 < 0.05
Subcategories costs (CNY)  
 Supplies cost 3760.4 (± 15,171.77) 5158.4 (± 9740.56) − 1398 0.382
 Pharmacy cost 3308.2 (± 3660.5) 4925.7 (± 5065.2) − 1617.5 < 0.05
 Examination cost 1551.1 (± 1403.78) 1957.2 (± 1742.96) − 406.1 < 0.05
 Laboratory cost 1365.6 (± 823.26) 1627.4 (± 1384.94) − 261.8 0.07
 Operation cost 2592.7 (± 2243.94) 4705.1 (± 3228.53) − 2112.4 < 0.05
 Treatment cost 462 (± 895.68) 1042 (± 1678.62) − 580 < 0.05
 Chinese patent drug cost 1334.9 (± 637.9) 145.6 (± 378.8) 1189.3 < 0.05